rs3808039

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005045.4(RELN):​c.8136A>G​(p.Leu2712Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0398 in 1,613,078 control chromosomes in the GnomAD database, including 1,896 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.047 ( 234 hom., cov: 32)
Exomes 𝑓: 0.039 ( 1662 hom. )

Consequence

RELN
NM_005045.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.151

Publications

14 publications found
Variant links:
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
SLC26A5-AS1 (HGNC:55680): (SLC26A5 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 7-103510989-T-C is Benign according to our data. Variant chr7-103510989-T-C is described in ClinVar as Benign. ClinVar VariationId is 95231.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.151 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.156 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RELNNM_005045.4 linkc.8136A>G p.Leu2712Leu synonymous_variant Exon 51 of 65 ENST00000428762.6 NP_005036.2 P78509-1
RELNNM_173054.3 linkc.8136A>G p.Leu2712Leu synonymous_variant Exon 51 of 64 NP_774959.1 P78509-2
SLC26A5-AS1NR_110141.1 linkn.1487-1780T>C intron_variant Intron 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RELNENST00000428762.6 linkc.8136A>G p.Leu2712Leu synonymous_variant Exon 51 of 65 5 NM_005045.4 ENSP00000392423.1 P78509-1

Frequencies

GnomAD3 genomes
AF:
0.0474
AC:
7207
AN:
152162
Hom.:
236
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0668
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.0256
Gnomad ASJ
AF:
0.0161
Gnomad EAS
AF:
0.166
Gnomad SAS
AF:
0.0778
Gnomad FIN
AF:
0.0189
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0352
Gnomad OTH
AF:
0.0508
GnomAD2 exomes
AF:
0.0475
AC:
11924
AN:
251214
AF XY:
0.0488
show subpopulations
Gnomad AFR exome
AF:
0.0652
Gnomad AMR exome
AF:
0.0165
Gnomad ASJ exome
AF:
0.0172
Gnomad EAS exome
AF:
0.175
Gnomad FIN exome
AF:
0.0198
Gnomad NFE exome
AF:
0.0349
Gnomad OTH exome
AF:
0.0342
GnomAD4 exome
AF:
0.0390
AC:
56993
AN:
1460798
Hom.:
1662
Cov.:
30
AF XY:
0.0403
AC XY:
29283
AN XY:
726806
show subpopulations
African (AFR)
AF:
0.0629
AC:
2102
AN:
33444
American (AMR)
AF:
0.0177
AC:
789
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
429
AN:
26120
East Asian (EAS)
AF:
0.158
AC:
6284
AN:
39664
South Asian (SAS)
AF:
0.0734
AC:
6330
AN:
86228
European-Finnish (FIN)
AF:
0.0200
AC:
1069
AN:
53410
Middle Eastern (MID)
AF:
0.0444
AC:
256
AN:
5764
European-Non Finnish (NFE)
AF:
0.0334
AC:
37127
AN:
1111138
Other (OTH)
AF:
0.0432
AC:
2607
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2558
5116
7675
10233
12791
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1460
2920
4380
5840
7300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0473
AC:
7202
AN:
152280
Hom.:
234
Cov.:
32
AF XY:
0.0467
AC XY:
3474
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0666
AC:
2770
AN:
41566
American (AMR)
AF:
0.0256
AC:
391
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0161
AC:
56
AN:
3472
East Asian (EAS)
AF:
0.166
AC:
857
AN:
5174
South Asian (SAS)
AF:
0.0775
AC:
374
AN:
4828
European-Finnish (FIN)
AF:
0.0189
AC:
201
AN:
10608
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0352
AC:
2395
AN:
68020
Other (OTH)
AF:
0.0517
AC:
109
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
349
698
1046
1395
1744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0367
Hom.:
194
Bravo
AF:
0.0476
Asia WGS
AF:
0.124
AC:
430
AN:
3476
EpiCase
AF:
0.0351
EpiControl
AF:
0.0365

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 21, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 03, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Norman-Roberts syndrome Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
1.9
DANN
Benign
0.67
PhyloP100
-0.15
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3808039; hg19: chr7-103151436; COSMIC: COSV58999854; API